|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C12N 15/11 | |
| C07H 21/00 | |||
| A61K 31/7088 | |||
| A61P 25/00 |
| (11) | Patento numeris | 2850190 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 13791546.8 |
| Europos patento paraiškos padavimo data | 2013-05-16 | |
| (97) | Europos patento paraiškos paskelbimo data | 2015-03-25 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-07-08 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2013/041394 |
| Data | 2013-05-16 |
| (87) | Numeris | WO 2013/173608 |
| Data | 2013-11-21 |
| (30) | Numeris | Data | Šalis |
| 201261648051 P | 2012-05-16 | US |
| (72) |
KRIEG, Arthur, M., US
SUBRAMANIAN, Romesh, US
MCSWIGGEN, James, US
LEE, Jeannie, T., US
|
| (73) |
The General Hospital Corporation,
55 Fruit Street, Boston, MA 02114,
US
Translate Bio MA, Inc., 29 Hartwell Avenue, Lexington, MA 02421, US |
| (54) | COMPOSITIONS AND METHODS FOR MODULATING MECP2 EXPRESSION |
| COMPOSITIONS AND METHODS FOR MODULATING MECP2 EXPRESSION |